Endoscopic treatment for reflux after gastric sleeve surgery
Part of Digestive system clinical trials.
This trial studies an endoscopic procedure to treat gastroesophageal reflux disease (GERD) in people who had gastric sleeve surgery. It may help if reflux symptoms are not controlled on once-daily acid medicine (PPI) or if you cannot tolerate it and want an alternative.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 or older).
- You have had gastric sleeve surgery before.
- You have confirmed GERD based on a scope exam or 24-hour acid testing.
- Your reflux symptoms are not adequately controlled on once-daily PPI, or you cannot tolerate PPIs, or you want to stop PPIs and are willing to try the procedure.
- You do not have a large hiatal hernia (more than 5 cm), and your esophagus has no preexisting narrowing.
- You do not have certain health issues/medication situations (for example, blood thinners/platelet medicines beyond aspirin) and your BMI is 35 or less.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a procedure called Endoscopic Cardial Constriction Ligation (ECCL) to help people whose acid reflux doesn't improve with strong medication. It uses a thin, flexible tube with a camera to tighten the valve between the stomach and esophagus.
This study tests a new, less invasive way to convert a sleeve gastrectomy into a different type of weight-loss surgery (SASI) in people who have ongoing gastroesophageal reflux or haven't lost enough weight. The goal is to see if this endoscopic procedure can improve reflux and help with weight loss without the need for a traditional surgery.
This trial tests whether an endoscopic fundoplication procedure (a reflux surgery done through the scope) using the MUSE system can better control long-term reflux symptoms. It likely fits people with chronic reflux confirmed by testing who may be candidates for surgical treatment.
This study looks at whether a treatment plan called “Sleeve-pex” can reduce heartburn and reflux after sleeve gastrectomy. If you’re planning this surgery and can complete symptom questionnaires, you may be able to join and help compare outcomes between groups.
This trial looks at how to predict who will develop acid reflux after a “stomach sleeve” operation. It may help doctors choose the safest plan before surgery and better prevent reflux afterward.
This trial tests a modified version of sleeve gastrectomy that aims to reduce the risk of acid reflux (GERD) after surgery. It is for people aged 18–65 with a BMI between 35 and 55 who already have some degree of GERD and are planning to have weight loss surgery.
Hear when a new Gastro Esophageal Reflux Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.